Successful Treatment of Eruptive Pruritic Papular Porokeratosis in the Elderly with Tofacitinib: A Case Report

• Published in: Clinical, cosmetic and investigational dermatology Vol. 16; pp. 1741 - 1747
• Main Authors: Mu, Xingyu, Li, Wen, Zhang, Ming, Yang, Changxiao, Yang, Xianxu, Li, Dan, Ding, Yan
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 31-07-2023; Dove; Dove Medical Press
• Subjects: Aged; Care and treatment; Case Report; Development and progression; eruptive pruritic papular porokeratosis; porokeratosis; Pruritus; Tofacitinib; China; porokeratosis; eruptive pruritic papular porokeratosis; tofacitinib
• ISSN: 1178-7015; 1178-7015
• DOI: 10.2147/CCID.S412495

Eruptive pruritic papular porokeratosis (EPPP) is a rare subtype of porokeratosis that presents as an acute exacerbation of an annular papule with a distinct peripheral hyperkeratotic ridge border and severe pruritus. EPPP is mainly reported in elderly East Asian men. Its etiology and pathogenesis are unknown. We hereby present a case report of EPPP in a 68-year-old Chinese male with persistent circumscribed papules on the extremities, accompanied by severe pruritus for one year. After the patient was given conventional medication, a new rash appeared on the patient's extremities and he felt intense itching in the area of the rash. The patient was switched to oral tofacitinib treatment. The patient felt that the pruritus had largely disappeared after one month of oral dosing, leaving only brown pigmentation on the erythema of the extremities. The patient has been off the drug for 2 months. There was no pruritus or new rash during the follow-up period.